Search

Claritrox Tablet

Claritrox Tablet

clarithromycin

Manufacturer:

SM Pharmaceuticals

Distributor:

SM Pharmaceuticals
Concise Prescribing Info
Contents
Clarithromycin
Indications/Uses
URTI eg, strep pharyngitis/tonsillitis, acute maxillary sinusitis; lower resp tract infections eg, bronchitis, pneumonia; acute otitis media; skin & skin structure infections eg, impetigo, folliculitis, cellulites, abscesses.
Click to view Claritrox Tablet detailed prescribing information
Dosage/Direction for Use
Adult 250 mg every 12 hr for 7 days. Severe infections 500 mg every 12 hr for 14 days. Renal impairment ½ adult dose.
Click to view Claritrox Tablet detailed prescribing information
Overdosage
View Claritrox Tablet overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to macrolide antibiotics. Co-administration w/ cisapride, pimozide, terfenadine, astemizole & ergot derivatives.
Click to view Claritrox Tablet detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Claritrox Tablet detailed prescribing information
Special Precautions
Hypersensitivity to erythromycin & other macrolides. Pseudomembranous colitis; superinfection. Prolonged or repeated use. Hepatic & renal impairment. Not to be used during pregnancy & lactation.
Click to view Claritrox Tablet detailed prescribing information
Adverse Reactions
Diarrhoea, nausea, abnormal taste, dyspepsia, abdominal pain/discomfort, headache.
Click to view Claritrox Tablet detailed prescribing information
Drug Interactions
Increased plasma conc of carbamazepine, terfenadine, omeprazole. Increased serum conc of digoxin; cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, quinidine/disopyramide, lovastatin, bromocriptine, valproate, astemizole & other CYP450-metabolised drugs. Decreased serum conc by rifabutin or rifampin. Increased AUC of theophylline. Potentiated effects of warfarin. Acute ergot toxicity w/ ergotamine or dihydroergotamine. Severe adverse effects w/ non-sedative antihistamines, astemizole, terfenadine & cisapride. Lowered Cmax, AUC & Tmax of zidovudine. Increased plasma conc by Maalox, ranitidine, omeprazole.
Click to view Claritrox Tablet detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Claritrox Tablet detailed prescribing information
Storage
View Claritrox Tablet storage conditions for details to ensure optimal shelf-life.
Description
View Claritrox Tablet description for details of the chemical structure and excipients (inactive components).
Action
View Claritrox Tablet mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Macrolides
ATC Classification
J01FA09 - clarithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Claritrox FC tab 250 mg
Packing/Price
3 × 10's
Form
Claritrox FC tab 500 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in